Living Diabetes is an evidence-based diabetes resource. Our editorial team curates clinical content from NICE, NHS, ADA and Diabetes UK guidelines to help readers understand and live well with diabetes.
BMI remains useful, but new obesity frameworks encourage clinicians to also consider waist-based measurements, health complications, and daily function when assessing people with diabetes.
Recent case reports have raised a rare but serious safety question involving semaglutide, poor intake, rapid weight loss, thiamine deficiency, and neurological symptoms. The evidence shows an association, not proven causation.
The FDA approved monthly Tryngolza for adults with severe hypertriglyceridemia. Here is what people with diabetes should know about its purpose, pancreatitis risk and safety.
A Lancet Diabetes & Endocrinology consensus statement highlights nutrition, muscle, function, GI symptoms, and psychological support during incretin therapy.
